Sundrug Co (SDGCF) Financial Statements

Compare

7 Followers

Sundrug Co Financial Overview

Sundrug Co's market cap is currently $2.87B. The company's EPS TTM is $0.48011486999999997; its P/E ratio is 14.05; and it has a dividend yield of 3.31%. Sundrug Co is scheduled to report earnings on February 12, 2026, and the estimated EPS forecast is $-0.85. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	¥ 801.81B	¥ 751.78B	¥ 690.46B	¥ 648.73B	¥ 634.31B
Gross Profit	¥ 186.81B	¥ 189.32B	¥ 171.95B	¥ 156.51B	¥ 158.55B
Operating Income	¥ 44.50B	¥ 41.00B	¥ 37.45B	¥ 34.05B	¥ 37.35B
EBITDA	¥ 61.89B	¥ 56.24B	¥ 49.52B	¥ 44.26B	¥ 46.01B
Net Income	¥ 30.75B	¥ 29.13B	¥ 25.70B	¥ 23.85B	¥ 25.33B
Balance Sheet
Cash & Short-Term Investments	¥ 64.96B	¥ 69.70B	¥ 80.87B	¥ 89.33B	¥ 86.50B
Total Assets	¥ 445.08B	¥ 421.31B	¥ 361.72B	¥ 325.77B	¥ 308.53B
Total Debt	¥ 39.48B	¥ 35.85B	¥ 939.00M	¥ 529.00M	¥ 114.00M
Net Debt	¥ -25.48B	¥ -33.84B	¥ -79.93B	¥ -88.80B	¥ -86.38B
Total Liabilities	¥ 175.37B	¥ 168.21B	¥ 125.39B	¥ 105.17B	¥ 103.37B
Stockholders' Equity	¥ 269.71B	¥ 253.09B	¥ 236.33B	¥ 220.59B	¥ 205.16B
Cash Flow
Free Cash Flow	¥ 7.71B	¥ 4.76B	¥ 12.59B	¥ 12.86B	¥ 15.94B
Operating Cash Flow	¥ 41.16B	¥ 41.19B	¥ 37.38B	¥ 31.68B	¥ 31.76B
Investing Cash Flow	¥ -35.37B	¥ -74.85B	¥ -28.51B	¥ -20.66B	¥ -17.90B
Financing Cash Flow	¥ -10.60B	¥ 22.49B	¥ -17.33B	¥ -8.19B	¥ -8.06B

Currency in JPY

Sundrug Co Earnings and Revenue History

Income Statement >

Sundrug Co Debt to Assets

Balance Sheet >

Sundrug Co Cash Flow

Cash Flow >

Sundrug Co Forecast EPS vs Actual EPS

Earnings >